Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia: A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma

Publikation: Bidrag til tidsskriftKommentar/debatfagfællebedømt

OriginalsprogEngelsk
TidsskriftActa Oncologica
Vol/bind59
Udgave nummer12
Sider (fra-til)1547-1551
ISSN0284-186X
DOI
StatusUdgivet - 2020

ID: 250555335